KLOW Blend 80mg Lyophilized Vial | Advanced Multi-Pathway Co-Lyophilized Matrix

Accelerate your complex tissue regeneration and multi-vector inflammatory assays with Alluvi Labs’ flagship KLOW Blend 80mg vial. This premier, precisely engineered master formulation combines four of the most extensively researched cellular repair sequences into a single, uniform matrix: BPC-157 (20mg), GHK-Cu (20mg), TB-500 (20mg), and KPV (20mg). By co-lyophilizing these foundational chemical structures simultaneously, this 80mg powerhouse eliminates the manual necessity of cross-vial measuring, radically optimizing fluid preparation timelines while removing the human margin of volumetric error.
Our vacuum-sealed 80mg combination units provide an unprecedented synergistic environment for advanced in vitro models tracking accelerated extracellular matrix reconstruction, synergistic cellular migration, and advanced systemic mast-cell stabilization.

Key Biochemical Characteristics & Purity Standards

To protect baseline data metrics and guarantee reproducible assay cycles, every component of the KLOW Blend is synthesized independently via solid-phase methods before entering integrated analytical validation:

• Verified Master Purity Profile: Exceeds 98% composite purity across all four underlying sequences, verified directly via High-Performance Liquid Chromatography (HPLC).
  
• Molar Ratio Precision: Formulated at an exact 1:1:1:1 mass weight distribution (20mg per active peptide structure) to ensure a perfectly predictable baseline concentration upon fluid reconstitution.
  
• Visual Baseline Check: Characterized by a signature, light-blue uniform lyophilized cake. The distinct blue hue provides immediate visual validation of the structural copper(II) chelation within the GHK-Cu molecule.
  
• Atmospheric Protection: Vacuum-sealed under an inert atmosphere layer within robust glass laboratory vials to shield the delicate amino acid sequences against oxidation or premature hydrolytic cleavage.

Investigated Preclinical Action Channels

In peer-reviewed cellular tracking and animal tissue models, the combined agents in the KLOW matrix cross-activate multiple biological pathways:

1. Angiogenesis & Extracellular Matrix Reconstruction (BPC-157 + TB-500): Studies indicate that BPC-157 upregulates growth hormone receptors while TB-500 binds to actin to promote rapid endothelial cell migration, creating a powerful dual-action vector for micro-vessel formation.
   
2. Fibroblast Activation & Collagen Alignment (GHK-Cu): Research demonstrates that the copper-chelated tripeptide coordination upregulates fundamental structural proteoglycans, stimulating dermal fibroblasts to optimize collagen alignment.
   
3. Advanced Anti-Inflammatory Signaling (KPV): The tripeptide KPV interacts directly with melanocortin 1 receptors (MC1R), downregulating pro-inflammatory nuclear factors (NF-kB) and suppressing inflammatory cytokines to allow unhindered cellular repair.

Product Specification Reference Table

Specification Parameter	Laboratory Standard Value
Blend Composition	BPC-157 (20mg) | GHK-Cu (20mg) | TB-500 (20mg) | KPV (20mg)
Molecular Forms	Acetate Salts / Lyophilized Pure Base (GHK-Cu)
Taste / Odor Profile	Odorless / Non-flavored Raw (Analytical Powder Matrix)
Total Active Content	80mg Co-Lyophilized Powder
Solubility Profile	Freely Soluble in Sterile Water / Physiological Saline

🔬 Preclinical Research Notice

This combination chemical matrix is synthesized strictly for in vitro laboratory analysis, cell culture profiling, and animal tissue repair models. It is absolutely not intended, authorized, or safe for human therapeutic injection, systemic healing use, injury recovery, cosmetic application, or direct dietary intake. All handling must be managed exclusively by qualified laboratory technicians.